Adalimumab-atto Subcutaneous

Uncategorized

Adalimumab-atto Subcutaneous

What is Adalimumab-atto Subcutaneous
?

Adalimumab-atto subcutaneous injection is a medication used to treat various autoimmune diseases. It is a biosimilar to adalimumab, which is a medication used to treat rheumatoid arthritis, Crohn’s disease, and various other conditions. Adalimumab-atto is a monoclonal antibody that binds to tumor necrosis factor (TNF), a protein that plays a role in the immune response. By blocking TNF, adalimumab-atto reduces inflammation and prevents damage to the joints, intestines, and other organs.

Benefits of Adalimumab-atto Subcutaneous
and Its Uses.

adalimumab-atto subcutaneous is a medication used to treat autoimmune diseases, including Crohn’s disease, ulcerative colitis, and rheumatoid arthritis. It is a tumor necrosis factor blocker, which means it blocks the activity of tumor necrosis factor (TNF), a protein that plays a role in inflammation. by blocking TNF, adalimumab-atto subcutaneous can help reduce inflammation and pain.

adalimumab-atto subcutaneous is given as a subcutaneous injection, meaning it is injected under the skin. It is available as a prefilled syringe or a pen.

adalimumab-atto subcutaneous is used to treat a wide variety of autoimmune diseases, including:

-Crohn’s disease
-ulcerative colitis
-rheumatoid arthritis
-ankylosing spondylitis
-psoriatic arthritis
-hidradenitis suppurativa

Side Effects and Dosage of Adalimumab-atto Subcutaneous

Adalimumab-atto (Humira) is a recombinant human monoclonal antibody that is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis. It is a TNF-inhibitor that binds to tumor necrosis factor-alpha (TNF-alpha) to prevent it from causing inflammation. Adalimumab-atto is available as a subcutaneous injection.

The recommended dosage of adalimumab-atto is 40 mg injected subcutaneously every other week.

Common side effects of adalimumab-atto include:

-Upper respiratory tract infections
-Headache
-Injection site reactions
-Nausea
-Diarrhea
-Abdominal pain
-Rash
-Fatigue

Adalimumab-atto should not be used in pregnant women or women

Category: Uncategorized
Posts created 12429

Leave a Reply

Your email address will not be published.

Related Posts

Begin typing your search term above and press enter to search. Press ESC to cancel.

Back To Top